Literature DB >> 33893358

Clinical characteristics and prognostic factors in hypertensive anterior uveitis diagnosed with polymerase chain reaction.

Seong-Wook Seo1, Seong-Jae Kim2, Woong-Sun Yoo3, Gyu-Nam Kim3, Inyoung Chung3, Min-Chul Cho4, Yong Seop Han5, Sang Soo Kang6, Seung Pil Yun7.   

Abstract

Aim of the study is to report the clinical characteristics and prognostic factors in hypertensive anterior uveitis (AU) diagnosed with multiplex polymerase chain reaction (PCR). Eighty-eight eyes of 88 patients with hypertensive AU were enrolled from 2015 to 2019 in a tertiary center in South Korea. All patients underwent multiplex PCR that was performed using aqueous humor samples collected at first visit to detect the DNA of six herpesviruses. Twenty-eight (31.8%) eyes were PCR positive. Herpes simplex virus was found in 6 (6.8%) eyes, varicella-zoster virus in 7 (8.0%) eyes, cytomegalovirus in 14 (15.9%) eyes, and Epstein-Barr virus in 1 (1.1%) eye. On multivariate regression analysis, PCR positivity was significantly associated with coin-shaped keratic precipitates (odds ratio (OR) = 6.01, P = 0.044). Recurrence and final visual acuity were significantly associated with a presumed diagnosis of viral endotheliitis (OR = 21.69, P = 0.04 and OR = 6.3, P = 0.004, respectively). This study showed the importance of PCR positivity, suggesting that identification of the virus through active PCR testing could affect the course, treatment, and prognosis of hypertensive AU.

Entities:  

Year:  2021        PMID: 33893358     DOI: 10.1038/s41598-021-87931-3

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  21 in total

1.  Clinical Results and Utility of Herpesviruses Multiplex Polymerase Chain Reaction: Assessment of Aqueous Humor Samples From Patients With Corneal Endotheliitis and High Intraocular Pressure.

Authors:  Gyu-Nam Kim; Min-Chul Cho; Woong-Sun Yoo; Rock-Bum Kim; Jin-Kwon Chung; Seong-Jae Kim
Journal:  J Glaucoma       Date:  2018-12       Impact factor: 2.503

2.  Possible role of cytomegalovirus infection in the etiology of the Posner-Schlossmann syndrome.

Authors:  E Bloch-Michel; E Dussaix; P Cerqueti; D Patarin
Journal:  Int Ophthalmol       Date:  1987-12       Impact factor: 2.031

3.  Characteristics and Clinical Outcomes of Hypertensive Anterior Uveitis.

Authors:  Narumon Keorochana; Isaraporn Treesit; Panrapee Funarunart
Journal:  Ocul Immunol Inflamm       Date:  2019-04-25       Impact factor: 3.070

4.  Prevalence and features of keratitis with quantitative polymerase chain reaction positive for cytomegalovirus.

Authors:  Michiko Kandori; Tomoyuki Inoue; Fumihiko Takamatsu; Yoshinao Kojima; Yuichi Hori; Naoyuki Maeda; Yasuo Tano
Journal:  Ophthalmology       Date:  2009-12-06       Impact factor: 12.079

Review 5.  Association of cytomegalovirus with idiopathic chronic anterior uveitis with ocular hypertension in Korean patients.

Authors:  Sung Wook Park; Hyeong Gon Yu
Journal:  Ocul Immunol Inflamm       Date:  2013-03-12       Impact factor: 3.070

Review 6.  Review of clinical and basic approaches to corneal endotheliitis.

Authors:  Yoshitsugu Inoue
Journal:  Cornea       Date:  2014-11       Impact factor: 2.651

7.  Utility of real-time PCR analysis for appropriate diagnosis for keratitis.

Authors:  Tomoyuki Inoue; Yuichi Ohashi
Journal:  Cornea       Date:  2013-11       Impact factor: 2.651

Review 8.  Demystifying viral anterior uveitis: A review.

Authors:  Nicole Shu-Wen Chan; Soon-Phaik Chee
Journal:  Clin Exp Ophthalmol       Date:  2018-11-13       Impact factor: 4.207

9.  Clinical features of cytomegalovirus anterior uveitis in immunocompetent patients.

Authors:  Soon-Phaik Chee; Kristine Bacsal; Aliza Jap; Su-Yun Se-Thoe; Ching Li Cheng; Ban Hock Tan
Journal:  Am J Ophthalmol       Date:  2008-02-06       Impact factor: 5.258

Review 10.  Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop.

Authors:  Douglas A Jabs; Robert B Nussenblatt; James T Rosenbaum
Journal:  Am J Ophthalmol       Date:  2005-09       Impact factor: 5.258

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.